STOCK TITAN

Adastra Holdings Ltd. Appoints New Director

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
management

Adastra Holdings Ltd. (symbol: XTXXF) appointed Calum Maschi as a director effective April 30, 2026, replacing Jonathan Edwards who resigned.

Mr. Maschi is described as a construction professional with over fifteen years of experience on large industrial, institutional and infrastructure projects, including management roles on LNG Canada. The company thanked Mr. Edwards for his contributions.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") is pleased to announce that Calum Maschi has been appointed as a director of the Company in place of Jonathan Edwards who has resigned as a director, effective April 30, 2026.

Mr. Maschi is a construction professional with over fifteen years of experience across large scale industrial, institutional and infrastructure projects, including management roles on major projects such as LNG Canada.

The Company would like to thank Mr. Edwards for his contributions to the Company and wishes him success in his future endeavors.

About Adastra Holdings Ltd.

Adastra has become one of Canada's leaders in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. It serves non-medical and medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra's Phyto Extractions and Endgame Extracts brands are now well established with a growing distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Adastra partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market, with the ultimate aim of addressing the needs of patients. For more information, visit: www.adastraholdings.ca.

For additional information, please contact:
(778) 715 5011
info@adastraholdings.ca

Neither the Canadian Securities Exchange nor its Market Regulator (as the term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy of accuracy of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/295681

FAQ

Who is the new director appointed to Adastra Holdings (XTXXF) and when did the appointment take effect?

The new director is Calum Maschi, and the appointment took effect on April 30, 2026. According to the company, Mr. Maschi replaces Jonathan Edwards and joins the board with construction and project management experience.

What experience does Calum Maschi bring to Adastra Holdings (XTXXF)?

Calum Maschi has over fifteen years of construction experience on large industrial, institutional and infrastructure projects. According to the company, his background includes management roles on major projects such as LNG Canada.

Which director resigned from Adastra Holdings (XTXXF) before the April 30, 2026 change?

Jonathan Edwards resigned as a director, effective April 30, 2026. According to the company, Mr. Edwards stepped down and the company publicly thanked him for his contributions.

Will the appointment of Calum Maschi to Adastra Holdings (XTXXF) change the company’s operational focus?

The announcement states only a board appointment and does not specify operational changes. According to the company, Mr. Maschi’s expertise is in large-scale construction and project management, which may inform board-level oversight.

Where can investors find the official notice of Adastra Holdings (XTXXF) director change dated May 4, 2026?

Investors can find the official notice via the company’s published announcement dated May 4, 2026. According to the company, the release details the appointment of Calum Maschi and the resignation of Jonathan Edwards.